Sign In

Also in this Section

Public policy issues having a direct impact on the discipline are actively monitored and communicated by the Public Policy Committee, which is making recommendations to influence issues as they are raised in the nation's capital.

Liver Capitol Hill Day was Wednesday, April 18, 2018.

From AASLD News

The following articles were written by Lyle Dennis, of Cavarocchi – Ruscio – Dennis Associates. They are policy consultants to AASLD.

AASLD Deepens Its Relationship with Patient Groups
December 4, 2018

What Lies Ahead for Government Funding?
October 30, 2018

The Elimination of Viral Hepatitis: What are the Policy Issues?
October 2018

Congress Comes Back …To Look for the Exits
September 2018

Are Those Storm Clouds on the Funding Horizon?
July 2018

Common Rule Revisions Governing Most Federal Health Research Delayed Six Months
June 2018

Maybe it is Not Always the Feds that Need to Step Up
May 2018

No Sooner is FY18 Put to Rest …
May 2018

Congress Takes a Serious Look at Opioid-Related Infectious Diseases
March 2018

Keeping Our Eyes on the Prize
February 2018

Wednesday, April 18 – Mark it down!
January 2018

HCV Guidance

HCV Guidance Website Addresses Kidney Transplantation, Pregnancy and HCV in Children

CDC and the FY 2018

The CDC Coalition urges Congress to Provide $7.8 billion for the Centers for Disease Control and Prevention’s Programs in the FY 2018 [PDF]

More in Public Policy

AASLD Public and Clinical Policy Committee: 2017 Agenda [PDF]

FY18 Funding Letter to the Senate about Division of Viral Hepatitis [PDF]

 

 

AASLD Position on Treating Patients with Chronic Hepatitis C Virus

AASLD has always put the patient first by providing clinicians with the latest rigorous data on the best treatments for patients with liver diseases, including hepatitis C.

Read AASLD's position.